Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nubia Boechat

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry|November 9, 2020
Antimalarial and anti-inflammatory activities of new chloroquine and primaquine hybrids: Targeting the blockade of malaria parasite transmissionNubia Boechat, Rita C C Carvalho, Maria de Lourdes G Ferreira, et al.
Frontiers in Pharmacology|July 28, 2022
A Selective Adenylyl Cyclase 1 Inhibitor Relieves Pain Without Causing ToleranceGianna Giacoletti, Tatum Price, Lucas V B Hoelz, et al.
Chemical Biology & Drug Design|June 15, 2026
Cruzain Inhibitors for Chagas Disease: Anticorrelated Optimisation Landscapes and the Multiparametric Path to Clinical CandidatesCaroline Rodrigues Chaves Dos Reis, Hellen Valério Chaves Moura de Souza, Lidia Corrêa Parra, et al.
Molecules (Basel, Switzerland)|April 28, 2023
A Review of the Development of Multitarget Molecules against HIV-TB Coinfection PathogensDebora Inacio Leite, Stefany de Castro Bazan Moura, Maria da Conceição Avelino Dias, et al.
Bioorganic Chemistry|October 3, 2020
P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinonesDaniela de Luna Martins, Adriel Alves Borges, Nayane A do A E Silva, et al.
Acta Tropica|April 10, 2023
In silico and in vitro assessment of anti-Trypanosoma cruzi efficacy, genotoxicity and pharmacokinetics of pentasubstituted pyrrolic Atorvastatin-aminoquinoline hybrid compoundsCarlos Fernando Araujo-Lima, Rita de Cássia Castro Carvalho, Raiza Brandão Peres, et al.
Bioorganic & Medicinal Chemistry|June 10, 2019
New pyrazolopyrimidine derivatives as Leishmania amazonensis arginase inhibitorsLivia M Feitosa, Edson R da Silva, Lucas V B Hoelz, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Molluscicidal and Schistosomicidal Activities of 2-(1<i>H</i>-Pyrazol-1-<i>yl</i>)-1,3,4-thiadiazole DerivativesLeonardo da Silva Rangel, Daniel Tadeu Gomes Gonzaga, Ana Cláudia Rodrigues da Silva, et al.
European Journal of Medicinal Chemistry|November 7, 2020
Comparative study between the anti-P. falciparum activity of triazolopyrimidine, pyrazolopyrimidine and quinoline derivatives and the identification of new PfDHODH inhibitorsFlávia F Silveira, Juliana O de Souza, Lucas V B Hoelz, et al.
Journal of Bioenergetics and Biomembranes|November 3, 2023
In vitro evaluation of 2-(1H-pyrazol-1-yl)-1,3,4-thiadiazole derivatives against replicative and infective stages of Trypanosoma cruziAna Flávia Martins Faria, Caroline de Souza Ferreira Pereira, Guilherme Pegas Teixeira, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry|November 9, 2020
Antimalarial and anti-inflammatory activities of new chloroquine and primaquine hybrids: Targeting the blockade of malaria parasite transmissionNubia Boechat, Rita C C Carvalho, Maria de Lourdes G Ferreira, et al.
Frontiers in Pharmacology|July 28, 2022
A Selective Adenylyl Cyclase 1 Inhibitor Relieves Pain Without Causing ToleranceGianna Giacoletti, Tatum Price, Lucas V B Hoelz, et al.
Chemical Biology & Drug Design|June 15, 2026
Cruzain Inhibitors for Chagas Disease: Anticorrelated Optimisation Landscapes and the Multiparametric Path to Clinical CandidatesCaroline Rodrigues Chaves Dos Reis, Hellen Valério Chaves Moura de Souza, Lidia Corrêa Parra, et al.
Molecules (Basel, Switzerland)|April 28, 2023
A Review of the Development of Multitarget Molecules against HIV-TB Coinfection PathogensDebora Inacio Leite, Stefany de Castro Bazan Moura, Maria da Conceição Avelino Dias, et al.
Bioorganic Chemistry|October 3, 2020
P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinonesDaniela de Luna Martins, Adriel Alves Borges, Nayane A do A E Silva, et al.
Acta Tropica|April 10, 2023
In silico and in vitro assessment of anti-Trypanosoma cruzi efficacy, genotoxicity and pharmacokinetics of pentasubstituted pyrrolic Atorvastatin-aminoquinoline hybrid compoundsCarlos Fernando Araujo-Lima, Rita de Cássia Castro Carvalho, Raiza Brandão Peres, et al.
Bioorganic & Medicinal Chemistry|June 10, 2019
New pyrazolopyrimidine derivatives as Leishmania amazonensis arginase inhibitorsLivia M Feitosa, Edson R da Silva, Lucas V B Hoelz, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Molluscicidal and Schistosomicidal Activities of 2-(1<i>H</i>-Pyrazol-1-<i>yl</i>)-1,3,4-thiadiazole DerivativesLeonardo da Silva Rangel, Daniel Tadeu Gomes Gonzaga, Ana Cláudia Rodrigues da Silva, et al.
European Journal of Medicinal Chemistry|November 7, 2020
Comparative study between the anti-P. falciparum activity of triazolopyrimidine, pyrazolopyrimidine and quinoline derivatives and the identification of new PfDHODH inhibitorsFlávia F Silveira, Juliana O de Souza, Lucas V B Hoelz, et al.
Journal of Bioenergetics and Biomembranes|November 3, 2023
In vitro evaluation of 2-(1H-pyrazol-1-yl)-1,3,4-thiadiazole derivatives against replicative and infective stages of Trypanosoma cruziAna Flávia Martins Faria, Caroline de Souza Ferreira Pereira, Guilherme Pegas Teixeira, et al.
Pageof 8